{"rows":[{"id":5793,"title":"Behavioral effects of psychedelic and non-psychedelic serotonin 2A receptor agonist drugs in pigs","authors":"CA Madsen, M. Navarro, E. Kolesnik, D. Kazani, V. Shalgunov, M. Zabrocki, A. Nasser, D. Luethi, F. Holze, M.E. Liechti, S.S. Johansen, M.K.K. Nielsen, H.D. Hansen, G.M. Knudsen","journal":"Neuroscience Applied","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1016/j.nsa.2025.106824","pubmed_id":null,"openalex_id":"https://openalex.org/W7118016845","source_url":"https://doi.org/10.1016/j.nsa.2025.106824","substance_tags":"psilocybin,psilocin","topic_tags":"Pharmacology,Mechanism of Action,Receptor Pharmacology,Toxicity","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-09 08:25:13","last_checked":"2026-08-09 08:25:13","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2025.106824","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.nsa.2025.106824","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.106824","source_url":"https://doi.org/10.1016/j.nsa.2025.106824","doi":"10.1016/j.nsa.2025.106824","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5024,"title":"Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulatory effects in healthy humans","authors":"Klaus Richter Larsen, Drummond E-Wen McCulloch, Brice Ozenne, Ulrich Lindberg, Sophia Armand, M. Madsen, Dea Siggaard Stenbæk, Gitte M. Knudsen, Patrick M. Fisher","journal":"Neuroscience Applied","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1016/j.nsa.2022.100335","pubmed_id":null,"openalex_id":"https://openalex.org/W4313201140","source_url":"https://doi.org/10.1016/j.nsa.2022.100335","substance_tags":"psilocybin","topic_tags":"Pharmacology,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:43","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2022.100335","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2022.100335","source_url":"https://doi.org/10.1016/j.nsa.2022.100335","doi":"10.1016/j.nsa.2022.100335","pmid":"","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5023,"title":"Neurochemical properties of psilocybin in comparison to ketamine in vivo","authors":"A. Wojtas, A. Bysiek, Z. Szych, M. Herian, K. Gołembiowska","journal":"Neuroscience Applied","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1016/j.nsa.2022.100408","pubmed_id":null,"openalex_id":"https://openalex.org/W4313201121","source_url":"https://doi.org/10.1016/j.nsa.2022.100408","substance_tags":"psilocybin","topic_tags":"Depression,Pharmacology,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:43","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2022.100408","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.nsa.2022.100408","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2022.100408","source_url":"https://doi.org/10.1016/j.nsa.2022.100408","doi":"10.1016/j.nsa.2022.100408","pmid":"","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5022,"title":"Differential effects of repeated treatment with DOI and psilocybin on the head-twitch response (HTR), locomotor activity and anxiety-like behaviour","authors":"E. Stojek, Jack Prenderville, F. Dunphy-Doherty","journal":"Neuroscience Applied","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1016/j.nsa.2022.100764","pubmed_id":null,"openalex_id":"https://openalex.org/W4313200992","source_url":"https://doi.org/10.1016/j.nsa.2022.100764","substance_tags":"psilocybin","topic_tags":"Anxiety,Observational Study","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:43","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2022.100764","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.nsa.2022.100764","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2022.100764","source_url":"https://doi.org/10.1016/j.nsa.2022.100764","doi":"10.1016/j.nsa.2022.100764","pmid":"","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5021,"title":"Effects of psilocybin in relative and global cerebral blood flow and behavioural correlates","authors":"Nathalie M. Rieser, Ladina P Gubser, Franz X. Vollenweider, Meyer Lars, Katrin H. Preller","journal":"Neuroscience Applied","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1016/j.nsa.2022.100702","pubmed_id":null,"openalex_id":"https://openalex.org/W4313200870","source_url":"https://doi.org/10.1016/j.nsa.2022.100702","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:43","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2022.100702","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2022.100702","source_url":"https://doi.org/10.1016/j.nsa.2022.100702","doi":"10.1016/j.nsa.2022.100702","pmid":"","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5020,"title":"Neurochemical and behavioural characterisation of the psychedelic 5HT2AR agonist psilocybin in mice","authors":"Ines Erkizia-Santamaría, R. Alles-Pascual, Igor Horrillo, Albert Adell, J. Javier Meana, J.E. Ortega","journal":"Neuroscience Applied","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1016/j.nsa.2022.100407","pubmed_id":null,"openalex_id":"https://openalex.org/W4313200261","source_url":"https://doi.org/10.1016/j.nsa.2022.100407","substance_tags":"psilocybin","topic_tags":"Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study","study_type":"Animal Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:43","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2022.100407","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.nsa.2022.100407","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2022.100407","source_url":"https://doi.org/10.1016/j.nsa.2022.100407","doi":"10.1016/j.nsa.2022.100407","pmid":"","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5019,"title":"The effect of psilocybin and sleep manipulation on neuroplasticity and sleep architecture in rats","authors":"Lucie Olejníková, Klára Šíchová, K. Chona, Hynek Danda, Tomáš Páleníček","journal":"Neuroscience Applied","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1016/j.nsa.2022.100948","pubmed_id":null,"openalex_id":"https://openalex.org/W4313199668","source_url":"https://doi.org/10.1016/j.nsa.2022.100948","substance_tags":"psilocybin","topic_tags":"Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Drug Interactions","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:43","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2022.100948","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.nsa.2022.100948","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2022.100948","source_url":"https://doi.org/10.1016/j.nsa.2022.100948","doi":"10.1016/j.nsa.2022.100948","pmid":"","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5018,"title":"The role of psilocybin in memory consolidation in the animal model","authors":"K. Šíchová, K. Chona, Lucie Olejníková Ladislavová, T. Páleníček","journal":"Neuroscience Applied","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1016/j.nsa.2022.100953","pubmed_id":null,"openalex_id":"https://openalex.org/W4313199409","source_url":"https://doi.org/10.1016/j.nsa.2022.100953","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,Addiction,Receptor Pharmacology,Wellbeing,Creativity,Animal Study,Drug Interactions","study_type":"Animal Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:43","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2022.100953","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.nsa.2022.100953","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2022.100953","source_url":"https://doi.org/10.1016/j.nsa.2022.100953","doi":"10.1016/j.nsa.2022.100953","pmid":"","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5017,"title":"Acute change in functional brain entropy following psilocybin administration in healthy volunteers","authors":"Drummond E-Wen McCulloch, Anders Smærup Olsen, Dea Siggaard Stenbæk, Sophia Armand, M.K. Madsen, Gitte M. Knudsen, Patrick M. Fisher","journal":"Neuroscience Applied","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1016/j.nsa.2022.100701","pubmed_id":null,"openalex_id":"https://openalex.org/W4313199337","source_url":"https://doi.org/10.1016/j.nsa.2022.100701","substance_tags":"psilocybin","topic_tags":"Pharmacology,Healthy Volunteers","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:43","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2022.100701","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2022.100701","source_url":"https://doi.org/10.1016/j.nsa.2022.100701","doi":"10.1016/j.nsa.2022.100701","pmid":"","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5007,"title":"Comparison of subjective, autonomic, and endocrine effects of LSD and psilocybin in healthy subjects","authors":"Friederike Holze, Laura Ley, F. Müller, V. Nimmy, Anne Eckert, Matthias E. Liechti","journal":"Neuroscience Applied","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1016/j.nsa.2022.100075","pubmed_id":null,"openalex_id":"https://openalex.org/W4221097544","source_url":"https://doi.org/10.1016/j.nsa.2022.100075","substance_tags":"psilocybin","topic_tags":"Depression,Pharmacology,Biomarkers,Spirituality,Safety","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:43","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2022.100075","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.nsa.2022.100075","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2022.100075","source_url":"https://doi.org/10.1016/j.nsa.2022.100075","doi":"10.1016/j.nsa.2022.100075","pmid":"","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5006,"title":"Investigating cue-reactivity as biomarker for treatment success in psilocybin-assisted therapy for alcohol use disorder","authors":"Nathalie M. Rieser, Ladina P Gubser, C. Rossgoderer Da Silva, Franz X. Vollenweider, Marcus Herdener, Katrin H. Preller","journal":"Neuroscience Applied","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1016/j.nsa.2022.100102","pubmed_id":null,"openalex_id":"https://openalex.org/W4220743600","source_url":"https://doi.org/10.1016/j.nsa.2022.100102","substance_tags":"psilocybin","topic_tags":"Addiction,Biomarkers","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:43","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2022.100102","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.nsa.2022.100102","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2022.100102","source_url":"https://doi.org/10.1016/j.nsa.2022.100102","doi":"10.1016/j.nsa.2022.100102","pmid":"","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5005,"title":"The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial","authors":"G. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, D. Feifel, David J. Hellerstein, L. Marwood, S. Mistry, Metten Somers, S.C. Stansfield, J. Tsai, S. Williams, Allan H. Young, Sidney Zisook, E. Malievskaia","journal":"Neuroscience Applied","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1016/j.nsa.2022.100213","pubmed_id":null,"openalex_id":"https://openalex.org/W4313200620","source_url":"https://doi.org/10.1016/j.nsa.2022.100213","substance_tags":"psilocybin","topic_tags":"Depression,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Adolescents,Treatment-Resistant Depression,Safety,Adverse Events","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:43","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2022.100213","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.nsa.2022.100213","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2022.100213","source_url":"https://doi.org/10.1016/j.nsa.2022.100213","doi":"10.1016/j.nsa.2022.100213","pmid":"","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5002,"title":"The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial","authors":"G.M. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, David Feifel, David J. Hellerstein, N. Hewitt, L. Marwood, S. Mistry, Metten Somers, S.C. Stansfield, J. Tsai, S. Williams, Antony Young, Sidney Zisook, E. Malievskaia","journal":"Neuroscience Applied","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1016/j.nsa.2022.100511","pubmed_id":null,"openalex_id":"https://openalex.org/W4313199626","source_url":"https://doi.org/10.1016/j.nsa.2022.100511","substance_tags":"psilocybin","topic_tags":"Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:43","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2022.100511","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2022.100511","source_url":"https://doi.org/10.1016/j.nsa.2022.100511","doi":"10.1016/j.nsa.2022.100511","pmid":"","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5001,"title":"Pharmacokinetics and pharmacokinetic-pharmacodynamic relationship of oral psilocybin administration in healthy subjects","authors":"Friederike Holze, A. Becker, Karolina E. Kolaczynska, Urs Duthaler, Matthias E. Liechti","journal":"Neuroscience Applied","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1016/j.nsa.2022.100410","pubmed_id":null,"openalex_id":"https://openalex.org/W4313200314","source_url":"https://doi.org/10.1016/j.nsa.2022.100410","substance_tags":"psilocybin","topic_tags":"Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:43","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2022.100410","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2022.100410","source_url":"https://doi.org/10.1016/j.nsa.2022.100410","doi":"10.1016/j.nsa.2022.100410","pmid":"","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4889,"title":"Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labelling","authors":"Klaus Richter Larsen, Ulrich Lindberg, Brice Ozenne, Drummond E-Wen McCulloch, Sophia Armand, M. Madsen, Annette Johansen, Dea Siggaard Stenbæk, Gitte M. Knudsen, Patrick M. Fisher","journal":"Neuroscience Applied","publication_date":"2023-01-01","publication_year":2023,"doi":"10.1016/j.nsa.2023.102665","pubmed_id":null,"openalex_id":"https://openalex.org/W4390241281","source_url":"http://dx.doi.org/10.1016/j.nsa.2023.102665","substance_tags":"psilocybin","topic_tags":"Pharmacology,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:47","last_checked":"2026-08-09 08:25:38","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2023.102665","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2023.102665","source_url":"http://dx.doi.org/10.1016/j.nsa.2023.102665","doi":"10.1016/j.nsa.2023.102665","pmid":"","publication_date":"2023-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4888,"title":"Psilocybin rescues depressive phenotype and modulates serotonin-2A and glucocorticoid receptor mRNA expression in brain cortex of a stress animal model","authors":"Ines Erkizia-Santamaría, Guadalupe Rivero, Igor Horrillo, J. Javier Meana, Jorge E. Ortega","journal":"Neuroscience Applied","publication_date":"2023-01-01","publication_year":2023,"doi":"10.1016/j.nsa.2023.102452","pubmed_id":null,"openalex_id":"https://openalex.org/W4390223807","source_url":"http://dx.doi.org/10.1016/j.nsa.2023.102452","substance_tags":"psilocybin","topic_tags":"Depression,Pharmacology,Receptor Pharmacology,Animal Study","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:47","last_checked":"2026-08-09 08:25:38","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2023.102452","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2023.102452","source_url":"http://dx.doi.org/10.1016/j.nsa.2023.102452","doi":"10.1016/j.nsa.2023.102452","pmid":"","publication_date":"2023-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4887,"title":"The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up study","authors":"Guy M. Goodwin, Lindsey Marwood, S. Mistry, Anna Nowakowska, Zainib Shabir, H. Clifton Simmons, E.K. Teoh, Jeng-Yu Tsai, E. Malievskaia","journal":"Neuroscience Applied","publication_date":"2023-01-01","publication_year":2023,"doi":"10.1016/j.nsa.2023.102906","pubmed_id":null,"openalex_id":"https://openalex.org/W4390223380","source_url":"http://dx.doi.org/10.1016/j.nsa.2023.102906","substance_tags":"psilocybin","topic_tags":"Depression,Observational Study,Treatment-Resistant Depression,Safety","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:47","last_checked":"2026-08-09 08:25:38","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2023.102906","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2023.102906","source_url":"http://dx.doi.org/10.1016/j.nsa.2023.102906","doi":"10.1016/j.nsa.2023.102906","pmid":"","publication_date":"2023-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4886,"title":"Effect of co-administration of low doses of psilocybin and mGluR2/3 antagonist LY341495 in chronic restraint stress model of depression","authors":"Agata Machaczka, Jane Turek, Dorota Bederska-Łojewska, Bartłomiej Pochwat, Łukasz Gąsior, Bernadeta Szewczyk, Andrzej Pilc","journal":"Neuroscience Applied","publication_date":"2023-01-01","publication_year":2023,"doi":"10.1016/j.nsa.2023.102939","pubmed_id":null,"openalex_id":"https://openalex.org/W4390223307","source_url":"https://doi.org/10.1016/j.nsa.2023.102939","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:47","last_checked":"2026-08-09 08:25:38","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2023.102939","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2023.102939","source_url":"https://doi.org/10.1016/j.nsa.2023.102939","doi":"10.1016/j.nsa.2023.102939","pmid":"","publication_date":"2023-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4885,"title":"Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J mice","authors":"Sofia Nasini, Martina Colognesi, Sara Tidei, Sara De Martin, Marco Banzato, Andrea Mattarei, Franco Folli, P. Marco, Paolo L. Manfredi, Stefano Comai","journal":"Neuroscience Applied","publication_date":"2023-01-01","publication_year":2023,"doi":"10.1016/j.nsa.2023.103378","pubmed_id":null,"openalex_id":"https://openalex.org/W4390222334","source_url":"http://dx.doi.org/10.1016/j.nsa.2023.103378","substance_tags":"psilocybin","topic_tags":"Pharmacology,Receptor Pharmacology,Animal Study","study_type":"Animal Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:47","last_checked":"2026-08-09 08:25:38","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2023.103378","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2023.103378","source_url":"http://dx.doi.org/10.1016/j.nsa.2023.103378","doi":"10.1016/j.nsa.2023.103378","pmid":"","publication_date":"2023-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4884,"title":"Withdrawal of antidepressants does not impact the efficacy of COMP360 psilocybin therapy: results from a phase IIb randomised controlled trial","authors":"Guy M. Goodwin, Megan Croal, J. Chai-Rees, Lindsey Marwood, S. Mistry, Anna Nowakowska, H. Clifton Simmons, Jeng-Yu Tsai","journal":"Neuroscience Applied","publication_date":"2023-01-01","publication_year":2023,"doi":"10.1016/j.nsa.2023.103487","pubmed_id":null,"openalex_id":"https://openalex.org/W4390222321","source_url":"http://dx.doi.org/10.1016/j.nsa.2023.103487","substance_tags":"psilocybin","topic_tags":"Clinical Trial,Randomized Controlled Trial","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:47","last_checked":"2026-08-09 08:25:38","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2023.103487","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2023.103487","source_url":"http://dx.doi.org/10.1016/j.nsa.2023.103487","doi":"10.1016/j.nsa.2023.103487","pmid":"","publication_date":"2023-01-01","importer_version":"2.1.3","text_redistributed":false}}],"total":57,"page":1,"per_page":20,"pages":3,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Neuroscience Applied","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}